Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
To Issue 144 Citation: Su A, “Say “No More” to Needles: Needle-Free Self-Injection Technology for Painless, Better Care”. ONdrugDelivery, Issue 144 (Mar/Apr 2023), pp 16–18. Alina Su discusses the need for improved and optimised remote healthcare to meet current challenges in the industry, and introduces Telosis, the company’s patent-pending connected needle-free injection device that is poised to provide answers to these challenges.
NovaXS Biotech is a smart medical device start-up focused on advanced drug delivery and patients’ long-term health. Its patent-pending technology, Telosis, is a needle-free drug delivery platform that allows patients to self-administer biologics subcutaneously or intramuscularly and track long-term treatment progress through IoT integration and a software app. NovaXS was founded in 2021.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
